Maarten S. van Leeuwen

Heidelberg University, University Medical Center Utrecht

Papers

2

Total Citations

190

H-Index

2

About

Maarten S. van Leeuwen is a pioneering surgeon whose work has redefined the standard of care in esophageal cancer surgery. His primary research focuses on minimally invasive surgical techniques, particularly robot-assisted procedures for complex gastrointestinal and oncologic conditions. Dr. van Leeuwen is best known as the lead author of the landmark ROBOT trial (2012), a randomized controlled trial that directly compared robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with open transthoracic esophagectomy for resectable esophageal cancer. This highly influential study, cited over 179 times, provided critical evidence supporting the safety and feasibility of robotic approaches in this challenging operation. Beyond his work in esophageal cancer, Dr. van Leeuwen has contributed to the literature on rare surgical pathologies, such as epithelial cysts in intrapancreatic accessory spleens, demonstrating the versatility of robot-assisted techniques in spleen-preserving distal pancreatectomy. His research has helped establish robotic surgery as a viable and increasingly preferred alternative to traditional open procedures, significantly impacting surgical practice and patient outcomes in the field of upper gastrointestinal oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
190
Total Citations
95
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Heidelberg University, University Medical Center Utrecht

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 22 days ago